Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Thrombospondin-1/CD36 pathway contributes to bone marrow-derived angiogenic cell dysfunction in type 1 diabetes via Sonic hedgehog pathway suppression.

Wang JM, Isenberg JS, Billiar TR, Chen AF.

Am J Physiol Endocrinol Metab. 2013 Dec;305(12):E1464-72. doi: 10.1152/ajpendo.00516.2013. Epub 2013 Oct 22.

2.

MicroRNA miR-27b rescues bone marrow-derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus.

Wang JM, Tao J, Chen DD, Cai JJ, Irani K, Wang Q, Yuan H, Chen AF.

Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):99-109. doi: 10.1161/ATVBAHA.113.302104. Epub 2013 Oct 31.

3.

Oxidative stress-mediated thrombospondin-2 upregulation impairs bone marrow-derived angiogenic cell function in diabetes mellitus.

Bae ON, Wang JM, Baek SH, Wang Q, Yuan H, Chen AF.

Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1920-7. doi: 10.1161/ATVBAHA.113.301609. Epub 2013 May 30.

4.

Sonic hedgehog improves ischemia-induced neovascularization by enhancing endothelial progenitor cell function in type 1 diabetes.

Qin Y, He YH, Hou N, Zhang GS, Cai Y, Zhang GP, Xiao Q, He LS, Li SJ, Yi Q, Luo JD.

Mol Cell Endocrinol. 2016 Mar 5;423:30-9. doi: 10.1016/j.mce.2016.01.005. Epub 2016 Jan 7.

PMID:
26773732
5.

Sonic hedgehog improves delayed wound healing via enhancing cutaneous nitric oxide function in diabetes.

Luo JD, Hu TP, Wang L, Chen MS, Liu SM, Chen AF.

Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E525-31. doi: 10.1152/ajpendo.00308.2009. Epub 2009 Jun 16.

6.

GTP cyclohydrolase I prevents diabetic-impaired endothelial progenitor cells and wound healing by suppressing oxidative stress/thrombospondin-1.

Tie L, Chen LY, Chen DD, Xie HH, Channon KM, Chen AF.

Am J Physiol Endocrinol Metab. 2014 May 15;306(10):E1120-31. doi: 10.1152/ajpendo.00696.2013. Epub 2014 Mar 18.

PMID:
24644242
7.

Impaired sonic hedgehog pathway contributes to cardiac dysfunction in type 1 diabetic mice with myocardial infarction.

Xiao Q, Hou N, Wang YP, He LS, He YH, Zhang GP, Yi Q, Liu SM, Chen MS, Luo JD.

Cardiovasc Res. 2012 Sep 1;95(4):507-16. doi: 10.1093/cvr/cvs216. Epub 2012 Jun 28.

PMID:
22745384
8.

Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling.

Asai J, Takenaka H, Kusano KF, Ii M, Luedemann C, Curry C, Eaton E, Iwakura A, Tsutsumi Y, Hamada H, Kishimoto S, Thorne T, Kishore R, Losordo DW.

Circulation. 2006 May 23;113(20):2413-24. Epub 2006 May 15.

9.

Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells.

Chu LY, Ramakrishnan DP, Silverstein RL.

Blood. 2013 Sep 5;122(10):1822-32. doi: 10.1182/blood-2013-01-482315. Epub 2013 Jul 29.

10.

c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.

Jiménez B, Volpert OV, Reiher F, Chang L, Muñoz A, Karin M, Bouck N.

Oncogene. 2001 Jun 7;20(26):3443-8.

11.

Extracellular Vesicles Activate a CD36-Dependent Signaling Pathway to Inhibit Microvascular Endothelial Cell Migration and Tube Formation.

Ramakrishnan DP, Hajj-Ali RA, Chen Y, Silverstein RL.

Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):534-44. doi: 10.1161/ATVBAHA.115.307085. Epub 2016 Jan 28.

12.
13.

Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice.

Vulesevic B, McNeill B, Geoffrion M, Kuraitis D, McBane JE, Lochhead M, Vanderhyden BC, Korbutt GS, Milne RW, Suuronen EJ.

Cardiovasc Res. 2014 Feb 1;101(2):306-16. doi: 10.1093/cvr/cvt259. Epub 2013 Nov 20.

PMID:
24259499
14.

CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.

Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD.

J Biol Chem. 2006 Sep 8;281(36):26069-80. Epub 2006 Jul 11.

15.

Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth.

Hale JS, Li M, Sinyuk M, Jahnen-Dechent W, Lathia JD, Silverstein RL.

PLoS One. 2012;7(7):e40033. doi: 10.1371/journal.pone.0040033. Epub 2012 Jul 10.

16.

Diazoxide accelerates wound healing by improving EPC function.

Li ZP, Xin RJ, Yang H, Jiang GJ, Deng YP, Li DJ, Shen FM.

Front Biosci (Landmark Ed). 2016 Jun 1;21:1039-51.

PMID:
27100489
17.

Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties.

Smadja DM, d'Audigier C, Bièche I, Evrard S, Mauge L, Dias JV, Labreuche J, Laurendeau I, Marsac B, Dizier B, Wagner-Ballon O, Boisson-Vidal C, Morandi V, Duong-Van-Huyen JP, Bruneval P, Dignat-George F, Emmerich J, Gaussem P.

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):551-9. doi: 10.1161/ATVBAHA.110.220624. Epub 2010 Dec 9.

18.

Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo.

Bongrazio M, Da Silva-Azevedo L, Bergmann EC, Baum O, Hinz B, Pries AR, Zakrzewicz A.

Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):35-48.

PMID:
16569344
19.

AMP-activated protein kinase rescues the angiogenic functions of endothelial progenitor cells via manganese superoxide dismutase induction in type 1 diabetes.

Wang XR, Zhang MW, Chen DD, Zhang Y, Chen AF.

Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E1135-45. doi: 10.1152/ajpendo.00001.2011. Epub 2011 Mar 22.

20.

Supplemental Content

Support Center